Please login to the form below
Amryt
This page shows the latest Amryt news and features for those working in and with pharma, biotech and healthcare.
NHS England says yes to Roche's Hemlibra
Amryt Pharma’s Lojuxta (lomitapide) for homozygous familial hypercholesterolaemia (HoFH) was ranked as a Level 3.
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Amryt Pharma appoints Jordi Casals as head of Europe
Dr Joe Wiley, chief executive officer of Amryt, said: “I am pleased to welcome Jordi to our senior management team as the company’s head of Europe. ... His significant commercial experience of European markets will help us to drive and further
-
Amryt Pharma appoints new regulatory affairs head
Prior to joining Amryt, she served as senior director of regulatory affairs for rare disease group Retrophin. ... Her new role will see her take responsibility for engagement with regulatory agencies and she will examine opportunities to pursue new
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Salary TBC
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
-
Senior Copywriter
-
Salary TBC
Subscribe to our email news alerts
- Leading AstraZeneca’s return to growth in Europe
- Eli Lilly shutters UK neuroscience unit, with 80 job losses expected
- Allergan investors back AbbVie deal, but is a tax charge looming?
- Bayer opens AI-enabled drug discovery center in UK
- Roche reports continued growth in Q3, despite biosimilar competition
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- The best in the UK healthcare system celebrated at QiC Diabetes awards 2019
- Merck wins CHMP recommendation for Ebola vaccine
- Roche scores another FDA approval for Xofluza
- CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal
- AZ and Daiichi get speedy review for rival to Roche’s HER2 drugs
- A snapshot of Crescendo Biologics
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...
Latest intelligence
- A snapshot of Crescendo Biologics
- PME talks to CEO Theodora Harold...
- eyeforpharma Marketing and Customer Innovation Europe
- By Richard Springham...
- The Golden Goose
- Why it’s so hard for the US to curb runaway drug prices...
Quick links
Infographics
